Investor alert: law offices of howard g. smith announces investigation of bioxcel therapeutics, inc. (btai) on behalf of investors

Bensalem, pa.--(business wire)--law offices of howard g. smith announces an investigation on behalf of bioxcel therapeutics, inc. (“bioxcel” or the “company”) (nasdaq: btai) investors concerning the company's possible violations of federal securities laws. on june 29, 2023, bioxcel disclosed that it is conducting an investigation into protocol adherence and data integrity at the principal investigator's trial site in connection with the company's tranquility ii clinical trial. bioxcel warned th.
BTAI Ratings Summary
BTAI Quant Ranking